Popova Called For An Early Vaccination

Popova Called For An Early Vaccination
Popova Called For An Early Vaccination

Video: Popova Called For An Early Vaccination

Video: COVID-19: Vaccines are safe for reproductive health | COVID-19 Special 2022, December
Anonim

The head of Rospotrebnadzor Anna Popova said that vaccination of the Russian population against coronavirus infection should be carried out as soon as possible. She made the corresponding statement during a conversation with reporters.

The head of the department claims that as soon as 60% of the country's population is vaccinated against the disease, the epidemiological situation will begin to stabilize. Herd immunity will help contain the spread of infection across the territory of the Russian Federation and help overcome the pandemic in the future.

It is very important today to conduct a vaccination campaign as quickly as possible, as effectively as possible, in order to first of all protect those who have not developed herd immunity today, '' said Popova.

The head of Rospotrebnadzor clarified that as soon as 60% of the country's population has developed immunity, it will be possible to assume that the epidemiological situation in Russia has been taken under control. However, this does not mean that even after achieving this result, vaccination will stop.

Earlier, as NEWS.ru wrote, the head of Rospotrebnadzor Anna Popova said that almost half of the residents of the Republic of Tatarstan are already immune to coronavirus infection. True, the head of the department did not clarify whether this immunity is a consequence of vaccination or whether it appeared in residents after an illness.

Prior to that, it was reported that Russian enterprises are technically ready to create such a number of vaccines against COVID-19, which is necessary to create population immunity. Viktor Dmitriev, General Director of the Association of Russian Pharmaceutical Manufacturers, spoke about this.

He noted that in addition to the Sputnik V and EpiVacCorona vaccines, a third drug will soon be registered in Russia, which is being developed by the Chumakov Scientific Center for Research and Development of Immunobiological Drugs. This, according to Dmitriev, will be "a great help."

Popular by topic